These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18646118)

  • 21. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.
    Klimas J; Tobin H; Field CA; O'Gorman CS; Glynn LG; Keenan E; Saunders J; Bury G; Dunne C; Cullen W
    Cochrane Database Syst Rev; 2014 Dec; (12):CD009269. PubMed ID: 25470303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.
    Mattick RP; Breen C; Kimber J; Davoli M
    Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD002209. PubMed ID: 19588333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.
    Mattick RP; Breen C; Kimber J; Davoli M
    Cochrane Database Syst Rev; 2003; (2):CD002209. PubMed ID: 12804430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.
    Mattick RP; Breen C; Kimber J; Davoli M
    Cochrane Database Syst Rev; 2002; (4):CD002209. PubMed ID: 12519570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maintenance agonist treatments for opiate dependent pregnant women.
    Minozzi S; Amato L; Vecchi S; Davoli M
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006318. PubMed ID: 18425946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological therapies for management of opium withdrawal.
    Rahimi-Movaghar A; Gholami J; Amato L; Hoseinie L; Yousefi-Nooraie R; Amin-Esmaeili M
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD007522. PubMed ID: 29929212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detoxification treatments for opiate dependent adolescents.
    Minozzi S; Amato L; Davoli M
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006749. PubMed ID: 19370651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychosocial treatment for opiate abuse and dependence.
    Mayet S; Farrell M; Ferri M; Amato L; Davoli M
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004330. PubMed ID: 15744796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Breen C; Kimber J; Davoli M
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD002207. PubMed ID: 24500948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral naltrexone maintenance treatment for opioid dependence.
    Minozzi S; Amato L; Vecchi S; Davoli M; Kirchmayer U; Verster A
    Cochrane Database Syst Rev; 2006 Jan; (1):CD001333. PubMed ID: 16437431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dihydrocodeine for detoxification and maintenance treatment in individuals with opiate use disorders.
    Carney T; Van Hout MC; Norman I; Dada S; Siegfried N; Parry CD
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD012254. PubMed ID: 32068247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2008 Apr; (2):CD002207. PubMed ID: 18425880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methadone at tapered doses for the management of opioid withdrawal.
    Amato L; Davoli M; Ferri M; Ali R
    Cochrane Database Syst Rev; 2002; (1):CD003409. PubMed ID: 11869660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.
    Klimas J; Field CA; Cullen W; O'Gorman CS; Glynn LG; Keenan E; Saunders J; Bury G; Dunne C
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009269. PubMed ID: 23152270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Slow-release oral morphine as maintenance therapy for opioid dependence.
    Ferri M; Minozzi S; Bo A; Amato L
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009879. PubMed ID: 23740540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heroin maintenance for chronic heroin-dependent individuals.
    Ferri M; Davoli M; Perucci CA
    Cochrane Database Syst Rev; 2010 Aug; (8):CD003410. PubMed ID: 20687073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inpatient versus other settings for detoxification for opioid dependence.
    Day E; Ison J; Strang J
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004580. PubMed ID: 15846721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2004; (3):CD002207. PubMed ID: 15266465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alphaâ‚‚-adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell M; Ali R; White JM
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD002024. PubMed ID: 27140827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2003; (2):CD002207. PubMed ID: 12804429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.